Jordan Andrew R Insider Trades

Insider Trading History

Track insider trading activity for Jordan Andrew R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Holding Value $10.8k 25,400 shares
Last Trade
Jan 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.8k 25,400 shares
$0.42
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Strategy Officer
Holding Value $192k 451,890 shares
Last Trade
Jan 17, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 402,529 shares
$0.42
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Strategy Officer
Holding Value $0 0 shares
Last Trade
Jan 17, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.91k 6,843 shares
$0.42
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director, CHIEF STRATEGY OFFICER
Holding Value $388k 913,082 shares
Last Trade
Jan 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$186k 261,718 shares
$0.71
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director, CHIEF STRATEGY OFFICER
Holding Value $357k 839,142 shares
Last Trade
Jan 06, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$52.5k 73,940 shares
$0.71
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Strategy Officer
Holding Value $277k 651,364 shares
Last Trade
Sep 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 651,364 shares
$0.38
$0.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up